Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures

Robert G. Miller; Benjamin Rix Brooks; Rebecca J. Swain-Eng; Robert C. Basner; Gregory T. Carter; Patricia Casey; Adam B. Cohen; Richard Dubinsky; Dallas Forshew; Carlayne E. Jackson; Ed Kasarskis; Nicholas J. Procaccini; Mohammed Sanjak; Fredrik P. Tolin

doi:10.3109/21678421.2013.875706

Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures

Robert G. Miller, Benjamin Rix Brooks, Rebecca J. Swain-Eng, Robert C. Basner, Gregory T. Carter, Patricia Casey, Adam B. Cohen, Richard Dubinsky, Dallas Forshew, Carlayne E. Jackson, Ed Kasarskis, Nicholas J. Procaccini, Mohammed Sanjak, Fredrik P. Tolin

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Original language	English
Pages (from-to)	165-168
Number of pages	4
Journal	Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume	15
Issue number	3-4
DOIs	https://doi.org/10.3109/21678421.2013.875706
State	Published - Jun 2014

Bibliographical note

Funding Information:
Dr. Miller has received research support from the Muscular Dystrophy, and is a consultant for Cytokinetics, Neuraltus, and Asubio pharmaceuticals. Dr. Brooks has received funding and/or research grants from AB Science, Acorda, ALS Therapy Alliance, Asubio, Avanir., Biogen Idec, Bristol-Myers Squibb, Cytokinetics, GlaxoSmithKline, Knopp Bioscience, Muscular Dystrophy Association, Neu-raltus, NINDS Clinical Research Consortium, QuestCor, and Teva. Ms. Swain-Eng is a full-time employee of the American Academy of Neurology. Dr. Basner is Principal Investigator of a Muscular Dystrophy Association grant,Opto-Electronic Plethysmography (OEP): A novel non-invasive quantitative assessment of lower rib cage paradox and use of accessory muscles in patients with amyotrophic lateral sclerosis; Site Investigator and Sleep Protocol Subcommittee member of an NHLBI/NIH grant, Sleep-Disordered Breathing During Pregnancy and Risks to Cardiovascular Health; and co-investigator of the following: R01HL103676-01A1 NIH/NHLBI; Subclinical Interstitial Lung Disease in MESA; R01HL093081 NIH/NHLBI; Pulmonary Vascular Changes in Early COPD; and InterMune PIPF-016: a randomized, double-blind, placebo-controlled, phase 3 study of the efficacy and safety of Pirfenidone in patients with Idiopathic Pulmonary Fibrosis (IPF). Dr. Carter reports no disclosures. Ms. Casey is a full-time employee of Northwestern Medical Faculty Foundation, Department of Neurology. Dr. Cohen reports no disclosures. Dr. Dubinsky reports disclosures for relationships with Allergan Pharmaceuticals, NIH, and AHRQ. Ms. Forshew is a consultant for Questcor and Asubio Pharmaceuticals. Dr. Jackson has received research support from Knopp Pharmaceuticals, Biogen Idec, and Cytoki-netics. Dr. Kasarskis is a consultant for Asubio Pharmaceuticals and ATSDR. Dr. Procaccini reports no disclosures. Dr. Sanjak reports no disclosures. Dr. Tolin reports no disclosures.

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.3109/21678421.2013.875706

Cite this

Miller, R. G., Brooks, B. R., Swain-Eng, R. J., Basner, R. C., Carter, G. T., Casey, P., Cohen, A. B., Dubinsky, R., Forshew, D., Jackson, C. E., Kasarskis, E., Procaccini, N. J., Sanjak, M., & Tolin, F. P. (2014). Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15(3-4), 165-168. https://doi.org/10.3109/21678421.2013.875706

@article{f4ae8d7a2f3c425ca6e7474964edf6c2,

title = "Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures",

author = "Miller, {Robert G.} and Brooks, {Benjamin Rix} and Swain-Eng, {Rebecca J.} and Basner, {Robert C.} and Carter, {Gregory T.} and Patricia Casey and Cohen, {Adam B.} and Richard Dubinsky and Dallas Forshew and Jackson, {Carlayne E.} and Ed Kasarskis and Procaccini, {Nicholas J.} and Mohammed Sanjak and Tolin, {Fredrik P.}",

note = "Funding Information: Dr. Miller has received research support from the Muscular Dystrophy, and is a consultant for Cytokinetics, Neuraltus, and Asubio pharmaceuticals. Dr. Brooks has received funding and/or research grants from AB Science, Acorda, ALS Therapy Alliance, Asubio, Avanir., Biogen Idec, Bristol-Myers Squibb, Cytokinetics, GlaxoSmithKline, Knopp Bioscience, Muscular Dystrophy Association, Neu-raltus, NINDS Clinical Research Consortium, QuestCor, and Teva. Ms. Swain-Eng is a full-time employee of the American Academy of Neurology. Dr. Basner is Principal Investigator of a Muscular Dystrophy Association grant,Opto-Electronic Plethysmography (OEP): A novel non-invasive quantitative assessment of lower rib cage paradox and use of accessory muscles in patients with amyotrophic lateral sclerosis; Site Investigator and Sleep Protocol Subcommittee member of an NHLBI/NIH grant, Sleep-Disordered Breathing During Pregnancy and Risks to Cardiovascular Health; and co-investigator of the following: R01HL103676-01A1 NIH/NHLBI; Subclinical Interstitial Lung Disease in MESA; R01HL093081 NIH/NHLBI; Pulmonary Vascular Changes in Early COPD; and InterMune PIPF-016: a randomized, double-blind, placebo-controlled, phase 3 study of the efficacy and safety of Pirfenidone in patients with Idiopathic Pulmonary Fibrosis (IPF). Dr. Carter reports no disclosures. Ms. Casey is a full-time employee of Northwestern Medical Faculty Foundation, Department of Neurology. Dr. Cohen reports no disclosures. Dr. Dubinsky reports disclosures for relationships with Allergan Pharmaceuticals, NIH, and AHRQ. Ms. Forshew is a consultant for Questcor and Asubio Pharmaceuticals. Dr. Jackson has received research support from Knopp Pharmaceuticals, Biogen Idec, and Cytoki-netics. Dr. Kasarskis is a consultant for Asubio Pharmaceuticals and ATSDR. Dr. Procaccini reports no disclosures. Dr. Sanjak reports no disclosures. Dr. Tolin reports no disclosures.",

year = "2014",

month = jun,

doi = "10.3109/21678421.2013.875706",

language = "English",

volume = "15",

pages = "165--168",

number = "3-4",

}

Miller, RG, Brooks, BR, Swain-Eng, RJ, Basner, RC, Carter, GT, Casey, P, Cohen, AB, Dubinsky, R, Forshew, D, Jackson, CE, Kasarskis, E, Procaccini, NJ, Sanjak, M & Tolin, FP 2014, 'Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 15, no. 3-4, pp. 165-168. https://doi.org/10.3109/21678421.2013.875706

TY - JOUR

T1 - Quality improvement in neurology

T2 - Amyotrophic Lateral Sclerosis Quality Measures

AU - Miller, Robert G.

AU - Brooks, Benjamin Rix

AU - Swain-Eng, Rebecca J.

AU - Basner, Robert C.

AU - Carter, Gregory T.

AU - Casey, Patricia

AU - Cohen, Adam B.

AU - Dubinsky, Richard

AU - Forshew, Dallas

AU - Jackson, Carlayne E.

AU - Kasarskis, Ed

AU - Procaccini, Nicholas J.

AU - Sanjak, Mohammed

AU - Tolin, Fredrik P.

N1 - Funding Information: Dr. Miller has received research support from the Muscular Dystrophy, and is a consultant for Cytokinetics, Neuraltus, and Asubio pharmaceuticals. Dr. Brooks has received funding and/or research grants from AB Science, Acorda, ALS Therapy Alliance, Asubio, Avanir., Biogen Idec, Bristol-Myers Squibb, Cytokinetics, GlaxoSmithKline, Knopp Bioscience, Muscular Dystrophy Association, Neu-raltus, NINDS Clinical Research Consortium, QuestCor, and Teva. Ms. Swain-Eng is a full-time employee of the American Academy of Neurology. Dr. Basner is Principal Investigator of a Muscular Dystrophy Association grant,Opto-Electronic Plethysmography (OEP): A novel non-invasive quantitative assessment of lower rib cage paradox and use of accessory muscles in patients with amyotrophic lateral sclerosis; Site Investigator and Sleep Protocol Subcommittee member of an NHLBI/NIH grant, Sleep-Disordered Breathing During Pregnancy and Risks to Cardiovascular Health; and co-investigator of the following: R01HL103676-01A1 NIH/NHLBI; Subclinical Interstitial Lung Disease in MESA; R01HL093081 NIH/NHLBI; Pulmonary Vascular Changes in Early COPD; and InterMune PIPF-016: a randomized, double-blind, placebo-controlled, phase 3 study of the efficacy and safety of Pirfenidone in patients with Idiopathic Pulmonary Fibrosis (IPF). Dr. Carter reports no disclosures. Ms. Casey is a full-time employee of Northwestern Medical Faculty Foundation, Department of Neurology. Dr. Cohen reports no disclosures. Dr. Dubinsky reports disclosures for relationships with Allergan Pharmaceuticals, NIH, and AHRQ. Ms. Forshew is a consultant for Questcor and Asubio Pharmaceuticals. Dr. Jackson has received research support from Knopp Pharmaceuticals, Biogen Idec, and Cytoki-netics. Dr. Kasarskis is a consultant for Asubio Pharmaceuticals and ATSDR. Dr. Procaccini reports no disclosures. Dr. Sanjak reports no disclosures. Dr. Tolin reports no disclosures.

PY - 2014/6

Y1 - 2014/6

UR - http://www.scopus.com/inward/record.url?scp=84901501437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901501437&partnerID=8YFLogxK

U2 - 10.3109/21678421.2013.875706

DO - 10.3109/21678421.2013.875706

M3 - Review article

C2 - 24707820

AN - SCOPUS:84901501437

SN - 2167-8421

VL - 15

SP - 165

EP - 168

JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

IS - 3-4

ER -

Quality improvement in neurology: Amyotrophic Lateral Sclerosis Quality Measures

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this